Monday, November 9, 2026

USD/EUR Is 2% Down In The Last 21 Sessions

USD/EUR Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.22% for the last 21 sessions. At 07:11 EST on Tuesday, 27 June, USD/EUR (USDEUR) is $0.91.

USD/EUR's yearly highs and lows, it's 1.265% up from its 52-week low and 12.917% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.02%, a negative 0.10%, and a positive 0.35%, respectively.

USD/EUR's highest amplitude of average volatility was 0.38% (last week), 0.33% (last month), and 0.35% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd pares recent losses around 1.0900 with eyes on eu/us inflation, ECB forum. According to FXStreet on Sunday, 25 June, "Failure to provide a daily closing below the 50-DMA, around 1.0870 by the press time, joins the nearly oversold RSI (14) line to trigger the EUR/USD pair's bounce towards the 10-DMA hurdle of 1.0920.", "On the other hand, Ning Jizhe, deputy head of the economic committee of the Chinese People's Political Consultative Conference (CPPCC) and a former vice head of the National Development and Reform Commission (NDRC) flagged concerns about sooner stimulus from China and allowed the EUR/USD to rebound, due to its business ties with Beijing. "
  • Eur/usd price analysis: retreats from 200-hma with eyes on ecb’s lagarde. According to FXStreet on Monday, 26 June, "Additionally, a horizontal area comprising multiple tops marked since June 16, close to 1.0945-50, acts as the last defense of the EUR/USD bears.", "On the contrary, the mid-June swing high around 1.0860 precedes the 50% Fibonacci retracement level of June 06-22 upside, near 1.0840, to limit the short-term downside of the EUR/USD pair."
  • Eur/usd trades with a mild positive bias just above 1.0900, lacks follow-through. According to FXStreet on Monday, 26 June, "That said, the Federal Reserve's (Fed) hawkish outlook could act as a tailwind for the buck and cap the EUR/USD pair. ", "Apart from this, the USD price dynamics should produce short-term opportunities around the EUR/USD pair. "
  • Eur/usd forecast: faces volatility amidst economic concerns and US dollar influence - 26 June 2023. According to DailyForex on Monday, 26 June, "The surge in volatility affecting most markets inevitably impacts the EUR/USD pair as well.", "Conversely, if risk aversion becomes more apparent, the EUR/USD pair may experience downward pressure. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com